Axogen, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
AXGN Nasdaq 3840 www.axogeninc.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Axogen, Inc.

Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock - Sep 10th, 2026 4:01 am
Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies - Sep 10th, 2026 4:00 am
Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference - Sep 1st, 2026 5:00 am
Axogen (AXGN) Q2 2026 Earnings Call Transcript - Aug 7th, 2026 7:28 pm
Axogen (AXGN) Is Up 5.1% After Raising 2026 Outlook On Breast Reconstruction Surge - Has The Bull Case Changed? - Jul 30th, 2026 2:08 am
Axogen Inc (AXGN) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amidst Margin Challenges - Jul 29th, 2026 1:03 pm
AxoGen Q2 Earnings Call Highlights - Jul 29th, 2026 8:04 am
AxoGen (AXGN) Tops Q2 Earnings and Revenue Estimates - Jul 29th, 2026 6:25 am
Trace Biosciences Announces Strategic Investment from Axogen to Advance Clinical Development of its Nerve Trace Nerve-Specific Imaging Technology - Jul 29th, 2026 5:10 am
Axogen, Inc. Reports Second Quarter 2026 Financial Results - Jul 29th, 2026 5:05 am
NZS Capital Added Axogen (AXGN) as an Optionality Position - Jul 21st, 2026 8:25 am
Nvidia Returns to NZS Growth Fund - Jul 21st, 2026 6:22 am
Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes - Jul 20th, 2026 2:05 pm
Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026 - Jul 15th, 2026 5:00 am
Dow Jones AI Giant Nvidia Stock Tumbles To Key Support Level Amid Market Sell-Off - Jun 9th, 2026 1:35 pm
Eli Lilly Leads Medical Stocks To Watch, While Google Finds Support - Jun 6th, 2026 6:00 am
AxoGen, Stock Of The Day, Offers Entry After Bullish Rebound - Jun 5th, 2026 1:57 pm
AxoGen Says Nerve Repair Strategy Intact as Reimbursement Wins Gather Steam - May 14th, 2026 9:06 am
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues - Apr 30th, 2026 2:43 pm